Cite
Production, purification and immunogenicity of Gag virus-like particles carrying SARS-CoV-2 components.
MLA
Gashti, Anahita Bakhshizadeh, et al. “Production, Purification and Immunogenicity of Gag Virus-like Particles Carrying SARS-CoV-2 Components.” Vaccine, vol. 42, no. 1, Jan. 2024, pp. 40–52. EBSCOhost, https://doi.org/10.1016/j.vaccine.2023.11.048.
APA
Gashti, A. B., Agbayani, G., Hrapovic, S., Nassoury, N., Coulombe, N., Dudani, R., Harrison, B. A., Akache, B., Gilbert, R., & Chahal, P. S. (2024). Production, purification and immunogenicity of Gag virus-like particles carrying SARS-CoV-2 components. Vaccine, 42(1), 40–52. https://doi.org/10.1016/j.vaccine.2023.11.048
Chicago
Gashti, Anahita Bakhshizadeh, Gerard Agbayani, Sabahudin Hrapovic, Nasha Nassoury, Nathalie Coulombe, Renu Dudani, Blair A. Harrison, Bassel Akache, Rénald Gilbert, and Parminder Singh Chahal. 2024. “Production, Purification and Immunogenicity of Gag Virus-like Particles Carrying SARS-CoV-2 Components.” Vaccine 42 (1): 40–52. doi:10.1016/j.vaccine.2023.11.048.